ResearcherUniversity of MichiganActive in the last 2 years
Roongruedee Chaiteerakij
Matched on ORCID iD 0000-0002-7191-3881; OpenAlex author ID A5024051594. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 2 papers
Papers 5
- Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III pancreatic ductal adenocarcinoma. First author DOI 10.1055/a-2535-7440↗
- Correction: Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III pancreatic ductal adenocarcinoma. First author DOI 10.1055/a-2571-2951↗
- Identification of breath volatile organic compounds to distinguish pancreatic adenocarcinoma, pancreatic cystic neoplasm, and patients without pancreatic lesio… Co-author DOI 10.4251/wjgo.v16.i3.894↗
- Application of artificial intelligence for diagnosis of pancreatic ductal adenocarcinoma by EUS: A systematic review and meta-analysis. Co-author DOI 10.4103/eus-d-20-00219↗
- Metformin Use and Survival of Patients With Pancreatic Cancer: A Cautionary Lesson. Co-author DOI 10.1200/jco.2015.63.3511↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Rungsun Rerknimitr · 4 shared papers, 2022–2025 · strength 0.94
- Paper Identification of breath volatile organic compounds to distinguish pancreatic adenocarcinoma, pancreatic cystic neoplas… DOI 10.4251/wjgo.v16.i3.894↗
- Paper Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III pancreatic ducta… DOI 10.1055/a-2535-7440↗
- Paper Correction: Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III panc… DOI 10.1055/a-2571-2951↗
- Pradermchai Kongkam · 3 shared papers, 2022–2025 · strength 0.66
- Paper Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III pancreatic ducta… DOI 10.1055/a-2535-7440↗
- Paper Correction: Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III panc… DOI 10.1055/a-2571-2951↗
- Paper Application of artificial intelligence for diagnosis of pancreatic ductal adenocarcinoma by EUS: A systematic review an… DOI 10.4103/eus-d-20-00219↗
- Thaninee Prasoppokakorn · 3 shared papers, 2022–2025 · strength 0.66
- Paper Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III pancreatic ducta… DOI 10.1055/a-2535-7440↗
- Paper Correction: Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III panc… DOI 10.1055/a-2571-2951↗
- Paper Application of artificial intelligence for diagnosis of pancreatic ductal adenocarcinoma by EUS: A systematic review an… DOI 10.4103/eus-d-20-00219↗
- Parit Mekaroonkamol · 3 shared papers, 2022–2025 · strength 0.66
- Paper Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III pancreatic ducta… DOI 10.1055/a-2535-7440↗
- Paper Correction: Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III panc… DOI 10.1055/a-2571-2951↗
- Paper Application of artificial intelligence for diagnosis of pancreatic ductal adenocarcinoma by EUS: A systematic review an… DOI 10.4103/eus-d-20-00219↗
- Phonthep Angsuwatcharakon · 2 shared papers, 2025 · strength 0.49
- Paper Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III pancreatic ducta… DOI 10.1055/a-2535-7440↗
- Paper Correction: Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III panc… DOI 10.1055/a-2571-2951↗
- Nipan Israsena · 2 shared papers, 2025 · strength 0.49
- Paper Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III pancreatic ducta… DOI 10.1055/a-2535-7440↗
- Paper Correction: Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III panc… DOI 10.1055/a-2571-2951↗
- Kasenee Tiankanon · 1 shared paper, 2024 · strength 0.28
- Emma R. Leof · 1 shared paper, 2016 · strength 0.06
- Lewis R Roberts · 1 shared paper, 2016 · strength 0.06
- Kari G. Rabe · 1 shared paper, 2016 · strength 0.06
- Ann L. Oberg · 1 shared paper, 2016 · strength 0.06
- David Bing Zhen · 1 shared paper, 2016 · strength 0.06
- Gloria M. Petersen · 1 shared paper, 2016 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.